Search

Your search keyword '"King, Sherita A"' showing total 23 results
Start Over Author "King, Sherita A"
23 results on '"King, Sherita A"'

2. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States

Author

Garraway, Isla P., primary, Carlsson, Sigrid V., additional, Nyame, Yaw A., additional, Vassy, Jason L., additional, Chilov, Marina, additional, Fleming, Mark, additional, Frencher, Stanley K., additional, George, Daniel J., additional, Kibel, Adam S., additional, King, Sherita A., additional, Kittles, Rick, additional, Mahal, Brandon A., additional, Pettaway, Curtis A., additional, Rebbeck, Timothy, additional, Rose, Brent, additional, Vince, Randy, additional, Winn, Robert A., additional, Yamoah, Kosj, additional, and Oh, William K., additional

Published
2024
Full Text
View/download PDF

7. Pudendal nerve block prior to inflatable penile prosthesis implantation: decreased intra-operative narcotic requirements

Author

Sayyid, Rashid K., Taylor, Nathaniel S., Owens-Walton, Jeunice, Oberle, Michael D., Fratino, Katherine L., Terris, Martha K., Klaassen, Zachary, and King, Sherita A.

Abstract

The opioid epidemic has proven to be a public health crisis over the past two decades and efforts to decrease opioid exposure are sorely needed. Our objective was to determine whether pudendal nerve block utilization in the immediate pre-operative setting decreases intra-operative opioid analgesic requirements in veteran patients undergoing a primary inflatable penile prosthesis implantation. We performed a retrospective cohort analysis of all patients undergoing penile prosthesis implantation between January 2017 and July 2020 at the Charlie Norwood Veterans Affairs Medical Center in Augusta, GA. Univariable and multivariable gamma regression analyses were performed to evaluate the association between pudendal nerve block utilization and intra-operative opioid analgesic requirements. The study cohort consisted of 110 patients, 35 (31.8%) of whom underwent a pudendal nerve block. Median intra-operative opioid analgesic requirements were significantly lower in the pudendal nerve block group (16.3 versus 25.8 morphine milliequivalents, p= 0.037). Receipt of the nerve block was associated with significantly lower intra-operative opioid analgesic requirements on multivariable (coefficient 0.84, p= 0.038) regression analysis. There was no significant difference in post-operative opioid analgesic requirements (p= 0.18). In conclusion, pre-operative pudendal nerve blocks decrease intra-operative opioid analgesic requirements in veteran patients undergoing a primary inflatable penile prosthesis implantation.

Published
2023
Full Text
View/download PDF

13. EDITORIAL COMMENT

Author

Lokeshwar, Soum D., primary, Benton, John Z., additional, King, Sherita A., additional, Terris, Martha K., additional, Wallis, Christopher J.D., additional, and Klaassen, Zachary, additional

Published
2020
Full Text
View/download PDF

22. Robot-Assisted Anatrophic Nephrolithotomy: Description of Technique and Early Results.

Author

King, Sherita A., Klaassen, Zachary, and Madi, Rabii

Subjects
*TREATMENT of calculi, *SURGICAL robots, *KIDNEY surgery, *BODY mass index, *GLOMERULAR filtration rate, *ISCHEMIA, *FOLLOW-up studies (Medicine)
Abstract

Purpose: To assess the feasibility and report early outcomes of robot-assisted anatrophic nephrolithotomy (RAN) as a treatment modality for patients with complex staghorn calculi. Patients and Methods: In this single-center prospective study, seven consecutive patients underwent RAN for complex staghorn calculi. After dissection to the renal hilum and clamping of the renal vessels, a nephrotomy was made along the Brodel line and dissection carried through the collecting system to the calculus. The stone was extracted, and the collecting system and parenchyma were closed in layers; no cooling of the kidney was performed. Results: The mean patient age was 47±16 years, mean body mass index was 31.9±10.0 kg/m2, and five of seven patients had complete staghorn calculi. Mean warm ischemia time was 35±7 minutes, mean robotic time was 158±51 minutes, and mean estimated blood loss was 121±39 mL. Mean length of stay was 3.0±1.7 days, and there was one perioperative complication. Five of seven patients had >90% reduction in stone burden, and two (29%) patients were completely stone free. Mean follow-up time was 5.1±4.3 months, and there was no decrease in postoperative estimated glomerular filtration rate compared with preoperative values. Conclusions: Our preliminary experience with RAN demonstrates a safe procedure with encouraging outcomes as a minimally invasive treatment modality for patients with extensive stone burden. Longer follow-up to determine the effect of RAN on renal function is needed. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

23. Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients.

Author

Klaassen, Zachary, Muller, Roberto, Qiang Li, Tatem, Alexander J., King, Sherita A., Freedland, Stephen J., Madi, Rabii, Terris, Martha K., and Moses, Kelvin A.

Subjects
PROSTATE cancer risk factors, DIAGNOSIS, PROSTATE cancer, PROSTATE cancer patients, PILOT projects, REGRESSION analysis, COHORT analysis, MARITAL status
Abstract

Objective. To assess the impact of comorbidity, race, and marital status on overall survival (OS) among men presenting for prostate biopsy with PSA >20 ng/mL. Methods. Data were reviewed from 2000 to 2012 and 78 patients were included in the cohort. We analyzed predictors of OS using a Cox proportional hazards model and the association between Charlson Comorbidity Index (CCI) score and PCa diagnosis or high-grade cancer using logistic regression and multinomial regression models, respectively. Results. The median age of patients was 62.5 (IQR 57-73) years. Median CCI was 3 (IQR 2-4), 69% of patients were African American men, 56% of patients were married, and 85% of patients had a positive biopsy. CCI (HR 1.52, 95% CI 1.19, 1.94), PSA (HR 1.62, 95% CI 1.09, 2.42), and Gleason sum (HR 2.04, 95% CI 1.17, 3.56) were associated with OS. CCI was associated with Gleason sum 7 (OR 4.06, 95% CI 1.04, 15.89) and Gleason sum 8-10 (OR 4.52, 95% CI 1.16, 17.54) PCa. Conclusions. CCI is an independent predictor of high-grade disease and worse OS among men with PCa. Race and marital status were not significantly associated with survival in this cohort. Patient comorbidity is an important component of determining the optimal approach to management of prostate cancer. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results